Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality.
about
Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cellsNovel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Clinical applications of palifermin: amelioration of oral mucositis and other potential indicationsThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesAltered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice.Keratinocyte growth factor improves repair in the injured tracheal epithelium.Molecular markers of radiation-related normal tissue toxicity.Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal InjuryModulation of specific intestinal epithelial progenitors by enteric neurons.Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracilCan we protect the gut in critical illness? The role of growth factors and other novel approaches.Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in miceReview of preclinical studies on treatment of mucositis and associated painKeratinocyte growth factor improves epithelial structure and function in a mouse model of intestinal ischemia/reperfusionA randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.Up-regulation of intestinal epithelial cell derived IL-7 expression by keratinocyte growth factor through STAT1/IRF-1, IRF-2 pathway.Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancerR-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway.An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamstersBiomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo.Role of thymic stromal lymphopoietin (TSLP) in palifermin-mediated immune modulation and protection from acute murine graft-versus-host diseaseOral mucositis induced by anticancer treatments: physiopathology and treatments.Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of agingIGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations.Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaquesA Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and EmesisProtected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers: A Triple-Blind, Randomized, Placebo-Controlled Trial.IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium.Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cyclingIncreased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositisMyofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells.Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands.Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends
P2860
Q21092205-B3209CE6-E4DE-4B5C-AE35-C8910859192CQ26823881-1C49687B-06B6-4789-AC2E-983330179CCEQ26852139-B5B54A36-FD13-4DE8-AC1C-B877ECD546FBQ28548012-C212E39F-B9CC-4EA4-A860-DE69C1F58A89Q30436376-6013CE95-2963-48E6-8212-21840EFA8416Q30441419-B580B3B0-1924-4970-A36B-0E492ED38FCDQ33568202-0EE68D09-75DD-4C3A-9E2B-1C0EA9FFA14EQ33745865-56B44D98-3BAF-45BA-A2ED-A7E74B63493FQ33774917-8CB8FAD5-E17B-48BD-947B-732BD0289FF2Q33947818-47C3B95F-3E53-4EEA-8463-4CD4AB94345FQ33985578-B032A161-F9C1-42E9-A9F4-5FC2D91C3C2AQ33990012-A5A21432-0844-4F84-B711-DA52D020AA59Q34014020-2BB46C47-3DEC-466B-8CD3-2EE60E99D315Q34080590-0FC4E103-239A-499C-B50E-189033C45091Q34421916-D9F5D429-BBE6-4B19-BB8E-6278086BF2B7Q34427411-0073DD71-01D5-4C85-BC11-2D3204C68C81Q34438006-48752556-B9F3-4123-A1FB-5EF706876F3BQ34577694-0F4532D4-1085-4B43-8D8C-FDA7A5FEF28EQ34648175-8950CFE9-F33F-44B9-89E6-6CE88FDADA84Q34836491-0423ACCC-C263-4CDC-8D32-FE27D93320D2Q34932642-981D66B9-6EA3-4DDA-A1D9-21C1782D6539Q35083450-2570C5B0-D331-4D6F-BAB3-09E239028FA7Q35094462-A715CF03-C458-47B6-9536-0BA7C8FDFBAAQ35097838-F8386D8E-EE84-4340-BD4C-395064B8E13AQ35166803-E3C7BAD0-12FE-4E21-ABC1-E4AA9D457A59Q35358052-0A4A8333-E485-494E-A1F8-B397703A8479Q35694784-0591E5FD-6772-46F1-AB9C-15C1AD6E4FEDQ35750903-788F8A37-2551-416B-A2A9-A7721F582CD2Q35774760-77EFC8DF-91C3-48EF-808A-1C4E051C1369Q35849064-2B047B6A-0207-4622-8AEB-EBE1785B44F8Q35989491-C8F6B366-19B2-4793-AB6E-00E7A770D7FCQ36015715-F66FC40C-3A84-49B9-8220-0DD8787FF0EBQ36282619-9B6F53F2-FEF4-49A5-BF48-CDC6531EDAB3Q36340179-D65EC8F2-B503-4577-B993-BB6C91338A32Q36602345-6C89B192-B0E8-4266-B8CE-390B8AD7CE11Q36624210-1984A49D-5819-4F05-9B21-CE39F08A04B0Q36641351-0FF3FF6D-7556-4A79-A205-CD5C5768FE4EQ36676237-F24F5D2F-FF3A-49AE-9ACA-6A8A81F38F23Q36837185-A5ED1D11-A47C-43B4-A794-5CAB26918579Q36955660-B1434CB4-6BC4-4061-8C77-5D1B95D6DF7D
P2860
Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Keratinocyte growth factor pro ...... testinal injury and mortality.
@en
Keratinocyte growth factor pro ...... testinal injury and mortality.
@nl
type
label
Keratinocyte growth factor pro ...... testinal injury and mortality.
@en
Keratinocyte growth factor pro ...... testinal injury and mortality.
@nl
prefLabel
Keratinocyte growth factor pro ...... testinal injury and mortality.
@en
Keratinocyte growth factor pro ...... testinal injury and mortality.
@nl
P2093
P1433
P1476
Keratinocyte growth factor pro ...... testinal injury and mortality.
@en
P2093
Aukerman SL
DiPalma CR
Farrell CL
P304
P407
P577
1998-03-01T00:00:00Z